home / stock / crxt / crxt news

CRXT News and Press, Clarus Therapeutics Holdings Inc. From 04/14/22

Stock Information
Company Name: Clarus Therapeutics Holdings Inc.
Stock Symbol: CRXT
Market: OTC
Website: clarustherapeutics.com
Menu
CRXT CRXT Quote CRXT Short CRXT News CRXT Articles CRXT Message Board
Get CRXT Alerts

News, Short Squeeze, Breakout and More Instantly...
CRXT - BioMed Momentum: VERU, NMLSF, PHRX, CRXT; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism

NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Clarus Therapeutics (NASDAQ...
CRXT - Best Penny Stocks to Buy? 3 to Watch as Musk Offers $43B for TWTR

What to Know About Buying Penny Stocks on April 14th, 2022 With another day of trading penny stocks here, there is a lot for investors to consider. Right now, the biggest news came as Elon Musk offered to buy 100% of Twitter Inc. ( NYSE: TWTR ) for $54 per share. Currently, the Tesl...

CRXT - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biggest pre-market stock movers for Thursday are ready and waiting so let’s see what’s moving the market today! Source: oneinchpunch/Shutterstock.com Moving stocks this morning are proposed public ...

CRXT - Cantor lists pharma stocks with notable changes in short interest

Referring to the most up-to-date market data as of Apr. 11, Cantor Fitzgerald has listed the biotech companies with the most notable changes in the short interest. The nano-cap commercial-stage pharma company, Clarus Therapeutics (CRXT) dominates the list with over ten times increase in short...
CRXT - Lixte, BioCardia top healthcare gainers; Hoth, Altamira lead losers' pack

Gainers: Lixte Biotechnology LIXT +263%. BioCardia BCDA +29%. Biodesix BDSX +27%. Aeglea BioTherapeutics AGLE +16%. Actinium Pharmaceuticals ATNM +14%. Losers: Hoth Therapeutics HOTH -30%. Altamira Therapeutics CYTO -29%. Myovant Sciences (MYO...

CRXT - ORIC, Unity Biotechnology top healthcare gainers; SELLAS, Pulse Biosciences lead losers' pack

Gainers: ORIC Pharmaceuticals (ORIC) +14%. Unity Biotechnology (UBX) +13%. Applied Therapeutics (APLT) +11%. Genetron (GTH) +11%. Clarus Therapeutics (CRXT) +8%. Losers: SELLAS Life Sciences SLS -39%. Pulse Biosciences (PLSE) -22%. Spero Therapeutics SPRO&#x...

CRXT - VTNR, MF and SABS among mid-day movers

Gainers: Longeveron (LGVN) +62%. Clovis Oncology (CLVS) +61%. Icosavax (ICVX) +26%. Integrated Media Technology (IMTE) +28%. SAB Biotherapeutics (SABS) +21%. Local Bounti (LOCL) +21%. CPS Technologies (CPSH) +18%. Vector Group (VGR) +17%. Nano-X Imaging (NNOX) +16%. Vertex Energy (VTNR) +16%....
CRXT - Clovis, Longeveron top healthcare gainers; while Clarus, Acutus among losers

Gainers: Clovis Oncology CLVS +68%. Longeveron LGVN +36%. Icosavax (ICVX) +27%. Creative Medical Technology (CELZ) +25%. Nano-X Imaging NNOX +22%. Losers: Clarus Therapeutics CRXT -27%. Acutus Medical AFIB -18%. Vyant Bio VYNT -15%. Phree...

CRXT - IQ, FUTU and VYNT among pre market losers

Arcadia Biosciences (RKDA) -25% on Q4 results. UiPath (PATH) -19% on Q4 results. Clarus Therapeutics (CRXT) -18% on Q4 results. Sharecare (SHCR) -15% on Q4 results. InflaRx (IFRX) -13% vilobelimab fails to show statistical significance in seve...

CRXT - Clarus Therapeutics Holdings' (CRXT) CEO Bob Dudley on Q4 2021 Results - Earnings Call Transcript

Clarus Therapeutics Holdings, Inc. (CRXT) Q4 2021 Earnings Conference Call March 30, 2022 5:15 PM ET Company Participants Bob Dudley – President and Chief Executive Officer Ric Peterson – Chief Financial Officer Frank Jaeger – Chief Commercial Officer Conference Call Part...
Previous 10 Next 10